metastatic-recurrent HNSCC (mHNSCC) | |
mHNSCC - L1 - all population | |
anti-PD-(L)1 | |
pembrolizumab based treatment | |
pembrolizumab alone | KEYNOTE-048 ... |
pembrolizumab plus 5FU plus platin | KEYNOTE-048 ... |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -